NIH-funded research U01 cooperative agreement

Rapid hip fracture surgery for patients with recent heart injury

Official title: HIP fracture Accelerated surgical TreaTment And Care tracK-2 (HIP ATTACK-2) trial

Funded at University of Maryland Baltimore · NIH-10897209 · Data updated 2026-11-12

This project compares having hip fracture surgery within six hours versus usual timing for people whose blood tests show an acute heart injury.

More Fracture research and trials

Quick facts

Grant typeU01 cooperative agreement
Study typeNIH-funded research
Funding institutionUniversity of Maryland Baltimore
NIH-funded
Lab location1 site (Baltimore, United States)
Project startAugust 1, 2022
Project endJuly 31, 2027
Funding year2025
Award (this year)$795,573
NIH project number5U01AR080377-03
Project IDNIH-10897209 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates are adults hospitalized with a hip fracture whose blood troponin is elevated, indicating a recent heart injury, and who can be randomized to different surgery timing.

Less likely to help

Patients without an elevated troponin, those who are too unstable for early surgery, or those who decline randomization are unlikely to receive benefit from this study's intervention.

What this research studies

If you arrive at the hospital with a broken hip and a blood test (troponin) shows acute heart injury, doctors would randomly assign you to have surgery within six hours or to receive the hospital's usual timing. The trial runs at multiple hospitals and follows patients for 90 days after surgery. Researchers will measure death rates, whether patients can walk 10 feet independently at 90 days, patient-reported quality of life, and medical or surgical complications. The goal is to confirm earlier findings that suggested people with heart injury fare better with earlier operations.

Why it matters

Potential benefit: If successful, faster surgery could lower the risk of death and improve recovery and quality of life after hip fracture for people with acute heart injury.

How similar studies have gone: Prior subgroup analyses suggested benefit from accelerated surgery in patients with elevated troponin, but this randomized trial is the first large, definitive test of that finding.

Where this research is happening

  • University of Maryland Baltimore
    Baltimore, United States
    Active

Researchers

  • Principal investigator: O'toole, Robert V. — University of Maryland Baltimore
  • Study coordinator: O'toole, Robert V.

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.